Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4486 to 4500 of 8314 results

  1. Does intensive monitoring of people at risk of diabetic foot disease reduce the morbidity associated with developing the disease and is such monitoring cost effective?

    Recommendation ID NG19/1 Question Does intensive monitoring of people at risk of diabetic foot disease reduce the morbidity associated

    Research recommendation
    Published
    15 November 2019

  2. Intensive monitoring for people at risk of diabetic foot problems:- Does intensive monitoring of people at risk of diabetic foot disease reduce the morbidity associated with developing the disease and is such monitoring cost effective?

    Recommendation ID NG19/1 Question Intensive monitoring for people at risk of diabetic foot problems:- Does intensive monitoring of people

    Research recommendation
    Published
    12 October 2015

  3. Further research should be in the form of randomised controlled trials or registries. It should report:

    Recommendation ID IPG778 Question Further research should be in the form of randomised controlled trials or registries. It should report:

    Research recommendation
    Published
    11 January 2024

  4. Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation over the long term, what is the clinical and cost effectiveness of single-use non-coated versus single-use hydrophilic versus single-use gel reservoir versus reusable non-coated catheters with regard to the following outcomes: symptomatic urinary tract infections, urinary tract infection-associated bacteraemia, mortality, patient comfort and preference, quality of life, and clinical symptoms of urethral damage?

    Recommendation ID CG139/3 Question Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation

    Research recommendation
    Published
    9 June 2015

  5. NICE encourages further research comparing ultrasound-enhanced, catheter-directed thrombolysis for deep vein thrombosis against catheter-directed thrombolysis alone. Patient selection should be documented, including the duration and extent of thrombosis. The dose of thrombolytic agent used and the duration of thrombolysis should be reported, together with all complications. Outcome measures should include the success of thrombolysis (complete, partial or failed) and long-term sequelae. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG523/1 Question NICE encourages further research comparing ultrasound-enhanced, catheter-directed thrombolysis for

    Research recommendation
    Published
    5 October 2015

  6. NICE encourages further research into arthroscopic trochleoplasty for patellar instability, including publication of consecutive patient series. Patient selection should be described in detail. Reported outcomes should include functional and quality‑of‑life measures, as well as reoperation rates.

    Recommendation ID IPG474/1 Question NICE encourages further research into arthroscopic trochleoplasty for patellar instability, including

    Research recommendation
    Published
    9 June 2015

  7. NICE encourages further research into balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Details of patient selection, all complications, and subsequent treatments and interventions for pulmonary hypertension should be collected. Reports should include quality-of-life outcomes, long-term efficacy outcomes and survival. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG554/1 Question NICE encourages further research into balloon pulmonary angioplasty for chronic thromboembolic pulmonary

    Research recommendation
    Published
    4 May 2016

  8. NICE encourages further research into intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer. Research should include randomised controlled trials, which stratify patients by risk and give adequate follow-up. They should report frequency of adverse events, patientreported outcome measures, overall and disease-free survival and quality of life.

    Recommendation ID IPG628/1 Question NICE encourages further research into intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive

    Research recommendation
    Published
    12 December 2018

  9. NICE encourages further research into CXL using riboflavin and UVA for keratoconus and keratectasia, especially epithelium-on (transepithelial) CXL and the combination (CXL-plus) procedures. Details of the techniques used should be clearly described. Reported outcomes should include visual acuity, corneal topography and quality of life. Data on long-term outcomes for all types of CXL using riboflavin and UVA for keratoconus and keratectasia would be useful – specifically data about prevention of progression to corneal transplantation and about repeat procedures and their efficacy.

    Recommendation ID IPG466/1 Question NICE encourages further research into CXL using riboflavin and UVA for keratoconus and keratectasia

    Research recommendation
    Published
    9 June 2015

  10. NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute heart failure. This should include clear documentation of patient selection and indications for the use of ECMO. Outcome measures should include survival, quality of life and neurological status.

    Recommendation ID IPG482/1 Question NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute

    Research recommendation
    Published
    9 June 2015

  11. NICE encourages further research into low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures. Further research should include details of patient selection, fracture site, and risk factors and comorbidities that delay fracture healing.

    Recommendation ID IPG623/1 Question NICE encourages further research into low-intensity pulsed ultrasound to promote healing of delayed-union

    Research recommendation
    Published
    11 December 2018

  12. NICE encourages further research into endoscopic radiofrequency ablation for Barrett's oesophagus with no dysplasia. Studies should define clearly the policies used for histological diagnosis. Outcomes should include complete resolution of Barrett's oesophagus, change and progression to low-grade dysplasia, high-grade dysplasia or cancer. All complications should be reported, particularly development of strictures. Comparative studies against surveillance would be useful.

    Recommendation ID IPG496/1 Question NICE encourages further research into endoscopic radiofrequency ablation for Barrett's oesophagus with

    Research recommendation
    Published
    9 June 2015

  13. NICE encourages further research into microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma, including randomised studies. Further research should include details of patient selection and long-term outcomes.

    Recommendation ID IPG612/1 Question NICE encourages further research into microinvasive subconjunctival insertion of a trans-scleral gelatin

    Research recommendation
    Published
    21 November 2018

  14. NICE encourages further research into endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus, including observational data collection. Studies should clearly define patient selection. Outcomes should include completeness of ablation, resolution of squamous dysplasia, progression to cancer and quality of life. All complications should be reported, particularly development of oesophageal strictures.

    Recommendation ID IPG497/1 Question NICE encourages further research into endoscopic radiofrequency ablation for squamous dysplasia of

    Research recommendation
    Published
    9 June 2015

  15. NICE encourages further research into micropressure therapy for refractory Ménière's disease. Research studies should report long-term outcomes, in particular the need for subsequent surgical treatment.

    Recommendation ID IPG426/1 Question NICE encourages further research into micropressure therapy for refractory Ménière's disease. Research

    Research recommendation
    Published
    9 June 2015